PTC Therapeutics
$42.979876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$42.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.11 (0.26%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell PTCT and other stocks, options, ETFs, and crypto commission-free!
About PTCT
PTC Therapeutics, Inc. Common Stock, also called PTC Therapeutics, is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. Read More It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
Employees
517
Headquarters
South Plainfield, New Jersey
Founded
1998
Market Cap
2.53B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
378.53K
High Today
$43.69
Low Today
$42.19
Open Price
$42.19
Volume
165.66K
52 Week High
$48.99
52 Week Low
$27.53
Collections
Price Paid on Robinhood
62% Higher
Right Now
52 Week Low
$25.48
Average Price Paid
$26.59
52 Week High
$52.95
Analyst Ratings
70%
of 10 ratings
Buy
70%
Hold
30%
Sell
0%
PTCT Earnings
-$1.29
-$0.85
-$0.41
$0.03
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 5, After Hours